Filter
2055
Filtered Results: 2055
Text search:
injecting
drug
use
Featured
Recommendations
226
New Publications
575
Language
Document type
No document type
1376
Guidelines
295
Studies & Reports
192
Manuals
80
Strategic & Response Plan
35
Training Material
30
Fact sheets
23
Situation Updates
10
Infographics
8
Resource Platforms
3
Brochures
2
App
1
Countries / Regions
India
190
Kenya
58
Nepal
55
Nigeria
49
Tanzania
48
South Africa
48
Ethiopia
48
Global
46
Western and Central Europe
46
Uganda
36
Ukraine
33
Myanmar / Burma
33
Zambia
30
Bangladesh
29
Ghana
25
Eastern Europe
25
Liberia
25
Sierra Leone
24
Malawi
23
Asia
23
Rwanda
22
Africa
19
Russia
19
Philippines
18
Namibia
18
Indonesia
16
Latin America and the Carribbean
13
Lesotho
11
Tajikistan
10
Albania
10
Zimbabwe
10
South–East Asia Region
10
Botswana
10
Georgia
9
Senegal
7
Cambodia
7
Middle East and North Africa
7
Cameroon
6
Haiti
6
Moldova
6
Eswatini/ Swaziland
6
Pakistan
6
Syria
5
Congo, Democratic Republic of
5
North Macedonia
4
Armenia
4
Brazil
4
Thailand
3
Estonia
3
USA
3
East and Southern Africa
3
Argentina
3
Colombia
2
Timor Leste/ East Timor
2
Iran
2
Kyrgyzstan
2
Burkina Faso
2
Morocco
2
Mozambique
2
Hungary
2
Jordan
2
West and Central Africa
2
Eastern Europe and Central Asia
2
Jamaica
2
Lebanon
2
Papua New Guinea
2
Sri Lanka
2
Sudan
2
Central African Republic
2
Poland
2
Bhutan
2
South Sudan
2
Iraq
2
Mexico
1
Serbia
1
Benin
1
Gambia
1
China
1
Kazakhstan
1
Canada
1
Fiji
1
Laos
1
Uzbekistan
1
Afghanistan
1
Malaysia
1
Mongolia
1
Guinea
1
Venezuela
1
Germany
1
Saudi Arabia
1
Western Pacific Region
1
North America
1
Uruguay
1
Tunisia
1
Norway
1
Portugal
1
Belarus
1
Southern Africa
1
Vietnam
1
Yemen
1
Romania
1
Greece
1
Palestine
1
Mali
1
Angola
1
Libya
1
Somalia
1
Solomon Islands
1
Authors & Publishers
Publication Years
Category
Countries
821
Clinical Guidelines
219
Public Health
88
Women & Child Health
76
Key Resources
41
Capacity Building
39
Pharmacy & Technologies
23
Toolboxes
HIV
398
TB
188
Mental Health
131
Pharmacy
90
COVID-19
67
AMR
57
NTDs
54
Ebola & Marburg
36
Caregiver
30
Refugee
26
Rapid Response
25
NCDs
25
Conflict
13
Polio
12
Global Health Education
10
Specific Hazards
9
Planetary Health
9
Cholera
7
Health Financing Toolbox
7
Disability
6
Natural Hazards
4
Malaria
3
Zika
2
Care and Support Centre (CSC) is a national initiative to provide expanded and holistic care and support services for PLHIV. The guideline focuses on the objectives, criteria for selection, required infrastructure, human resources, MIS tools, and financial guidelines for CSCs. This guideline will b...
This document provides an overview of key considerations for the provision of the HIV continuum of care in the context of displaced people from Ukraine in the EU/EEA. This document has two aims: firstly, to outline what is known of the Ukrainian HIV epidemic, and secondly, to use the HIV continuum o...
Language influences the way we think, how we perceive reality, and how we behave. With respect to HIV, language can embody stigma and discrimination, which impacts access to testing, acquisition of HIV, and engagement with treatment. Language plays a role in supporting respect and empowerment of ind...
Indicators for monitoring the 2016 United Nations Political Declaration on Ending AIDS
UNAIDS supports countries to collect information on their national HIV responses through the Global AIDS Monitoring (GAM) framework—an annual collection of 72 indicators on the response to HIV in a country....
UNAIDS supports countries to collect information on their national HIV responses through the Global AIDS Monitoring (GAM) framework—an annual collection of 72 indicators on the response to HIV in a country....
The Democratic Republic of Timor-Leste has the highest TB incidence rate in the South East Asian Region - 498 per 100,000, which is the seventh highest in the world. In Timor-Leste TB is the eighth most common cause of death.
The salient observations are as follows:
In 2018, 487 (12.5%) of the...
Following the encouraging initial results of the pilot project, the Ministry of Health is committed to increasing access to MDR-TB diagnosis, treatment and care. An expansion plan for the programmatic management of drug-resistant TB has been developed and forms part of the Five Year National Strateg...
The goal of this addendum is to help management and staff
minimize the risk of TB transmission at facilities in resource limited settings in which a.) HIV-infected persons receive diagnosis, care, treatment,
and/or support, and b.) there is a high prevalence of HIV infection, both known
and...
Arsenical monotherapies were previously very successful for treating human African trypanosomiasis (HAT).
Melarsoprol resistance emerged as early as the 1970s and was widespread by the late 1990s.
Melarsoprol resistance represents the only example of widespread drug resistance in HAT patients wher...
Acta Trop. 2020 Mar:203:105289. doi: 10.1016/j.actatropica.2019.105289
The role of malacological surveys to identify potential transmission sites for schistosomiasis control in this era of
mass drug administration have received little attention. In that context, the present study was conducted to
...
Effectiveness of Education and an Antibiotic-Control Program in a Tertiary Care Hospital in Thailand
Overuse of antimicrobial agents occurs globally in both community and hospital settings. Misuse of antibiotics can lead to a variety of adverse outcomes, including the development of antimicrobial resistanceand increased cost of hospitalization. This issuehas been particularly problematic in de...
The Cholera Q&A Fact Sheet provides essential information about cholera, including its causes, symptoms, treatment, and prevention. Cholera is an acute diarrheal disease caused by Vibrio cholerae, which spreads through contaminated water and food. It leads to rapid dehydration and can be fatal if un...
Guide for coordinators and data collectors - The WHO Operational Package for Assessing, Monitoring and Evaluating Country Pharmaceutical Situations is intended as a useful tool for researchers, policy-makers, planners and others who need to use standardized measurement tools to gather data and other...
July 2021. This publication brings together important clinical and programmatic updates produced by WHO since 2016 and provides comprehensive, evidence-informed recommendations and good practice statements within a public health, rights-based and person-centred approach.
These guidelines bring in...
3 March 2022
The WHO Therapeutics and COVID-19: living guideline contains the Organization’s most up-to-date recommendations for the use of therapeutics in the treatment of COVID-19. The latest version of this living guideline is available in pdf format (via the ‘Download’ button) and via an ...
• provide scientific information on the safety, efficacy, and quality control/ quality assurance of widely used medicinal plants, in order to facilitate their appropriate use in Member States;
• provide models to assist Member States in developing their own mono- graphs or formularies for these...
The internationally recognized criteria for diagnosis of neurocysticercosis include a requirement for neuroimaging techniques, such as computerized tomography (CT) and/or magnetic resonance imaging (MRI), ideally supported by serology. These facilities are not available in all settings, especially i...
This document provides guidance on how to implement contact screening and chemoprophylaxis with single-dose rifampicin. The contents are logically ordered: counselling and obtaining consent, identification and listing of index case, listing of contacts, tracing of contacts, screening of contacts, ad...
Evidence for technical update of pocket book recommendations. Newborn conditions, dysentery, pneumonia, oxygen use and delivery, common causes of fever, severe acute malnutrition and supportive care
Interim Assessement Report
The EMA review was started by the Agency’s Committee for Medicinal Products for Human Use (CHMP) to support decision-making by health authorities. This first interim report includes information on seven experimental medicines intended for the treatment of people infecte...
In case of resistance to rifampicin, fluoroquinolones become the preferred category of second-line drugs. Unfortunately, quinolone-resistant strains of Mycobacterium leprae have also been reported in several countries, probably due to the extensive use of quinolones for treating several types of inf...
